Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000930413-09-003196
Filing Date
2009-06-12
Accepted
2009-06-12 17:26:44
Documents
7
Period of Report
2008-10-31

Document Format Files

Seq Description Document Type Size
1 c57879_10ka.htm 10-K/A 1019743
2 GRAPHIC img1.gif GRAPHIC 7349
3 c57879_ex21.htm EX-21 1516
4 c57879_ex31-1.htm EX-31.1 5364
5 c57879_ex31-2.htm EX-31.2 5354
6 c57879_ex32-1.htm EX-32.1 2236
7 c57879_ex32-2.htm EX-32.2 2239
  Complete submission text file 0000930413-09-003196.txt   1048330
Mailing Address 5360 NORTHWEST 35TH AVENUE FT. LAUDERDALE FL 33309
Business Address 5360 NORTHWEST 35TH AVENUE FT. LAUDERDALE FL 33309 954-486-4590
Synovics Pharmaceuticals (Filer) CIK: 0001030839 (see all company filings)

EIN.: 860760991 | State of Incorp.: NV | Fiscal Year End: 1031
Type: 10-K/A | Act: 34 | File No.: 000-22011 | Film No.: 09890543
SIC: 2833 Medicinal Chemicals & Botanical Products